Fundamental Valuation Report Insmed(INSM:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$33.73 (USD) 04/30/2021 Weighted Valuation$31.94 (USD) Overall RatingOvervalued by 5.3% Valuation Models Comparables: $24.58 (USD) (in order of …
Insmed (INSM:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Apellis Pharmaceuticals(APLS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$44.76 (USD) 04/15/2021 Weighted Valuation$45.71 (USD) Overall RatingFairly valued to slightly Undervalued by 2.1% Valuation Models Comparables: $43.52 …
Apellis Pharmaceuticals (APLS:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Agios Pharmaceuticals(AGIO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$53.36 (USD) 04/14/2021 Weighted Valuation$58.00 (USD) Overall RatingUndervalued by 8.7% Valuation Models Comparables: $74.03 (USD) Multiples: $64.54 (USD) …
Agios Pharmaceuticals (AGIO:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Intellia Therapeutics(NTLA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$64.73 (USD) 03/26/2021 Weighted Valuation$49.50 (USD) Overall RatingOvervalued by 23.5% Valuation Models Comparables: $42.66 (USD) Valuation Methods …
Intellia Therapeutics (NTLA:NAS) Fundamental Valuation Report Read more »
Read MoreFundamental Valuation Report bluebird bio(BLUE:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$131.32 (USD) 22/02/2019 Weighted Valuation$154.06 (USD) Overall RatingUndervalued by 17.3% Valuation Models Analyst Consensus: $150.00 (USD) (in …
bluebird bio (BLUE:NAS) Fundamental Valuation Report Read more »
Read MorePrint This Report was generated using the tools available on StockCalc.com. Patchell Brook Equity Analytics Inc. emphasizes that the user assumes all risks associated with the use of this report or the Stockcalc website including, but not limited to, all …
ACADIA Pharmaceuticals (ACAD:NAS) Fundamental Valuation Report Read more »
Read MorePrint This Report was generated using the tools available on StockCalc.com. Patchell Brook Equity Analytics Inc. emphasizes that the user assumes all risks associated with the use of this report or the Stockcalc website including, but not limited to, all …
Agios Pharmaceuticals (AGIO:NAS) Fundamental Valuation Report Read more »
Read More